RNAZNasdaq United States
Market cap
$4.192 M
$3.96 -7.26%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$34.7M
Loss-making
Shares outstanding
916,968
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Transcode Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.